Is Bicara Therapeutics financially healthy?
Mostly
Bicara Therapeutics would need 1.9 years of earnings to pay off its debt, which is manageable.
The numbers behind it
Net debt / EBITDA1.9 years
Cash vs. debt$97M vs. $2M
Current ratio13.9×Short-term assets for each $1 of bills due within a year
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about Bicara Therapeutics
Data as of Nov 13, 2026.